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Identity 
Other names: STEAP; PRSS24; MGC19484 
HGNC (Hugo): STEAP1 
Location: 7q21.13 
Local order: Other genes in the vicinity of STEAP1 
include ZNF804B (zinc finger protein 804B), dpy-19-
like 2 pseudogene 4 (from C. elegans) and STEAP2. 
DNA/RNA 
Description 
10,4 kb consisting of 5 exons. 
Transcription 
1,330 kb transcript; 1195 bp ORF. 
Protein 
Description 
339 amino acids (NCBI: AF186249); MW 40 kDa, 
contains 6 transmembrane helical domains (table 1) and 
a theoretical pI of 9.28. 
Expression 
Cell lines: Prostate-LnCAP, LAPC4, PC3, DU145,  
breast-MCF7, melanoma-624mel, 697mel, 888mel, 
MM331, gastrointestinal tract-MKN45, WiDR, lung-
1355.  
Normal murine tissues: bone marrow, brain, colon, 
duodenum, liver, heart, ileum, kidney, lung, pancreas, 




STEAP1 was first identified as a prostate-specific cell-
surface antigen, over-expressed in human prostate 
cancer, and in the spontaneous transgenic mouse model 
of prostate cancer, by suppressive subtractive 
hybridization. It is also expressed in several human 
cancer cell lines obtained from prostate, breast, 
pancreas, bladder, gastrointestinal tract, testis, ovary, 
cervix, Ewing sarcoma, and melanomas, and in 
malignant tumours from several different tissues (eg. 
prostate, breast, bladder, lung), with little or no 
expression in vital organs. Recent data showed that 
STEAP1 is involved in intercellular communication 
between adjacent cells in culture, and that it seems to 
favour tumour development.  
 
 
Surrounding genes from Entrez (updated 12-Feb-2009). 
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STEAP gene organization, mRNA transcripts and predicted protein structure. Green boxes correspond to exons. 
 
Table 1-Sequence of the 6 transmembrane helices. 
 
Its structure prediction, and location at cell-cell 
junctions, suggest that STEAP1 must be a channel, or a 
transport protein. Its cell surface location in all tumour 
types analyzed so far, and its absence in most vital 
organs in humans, turned STEAP1 into a potential 
target for anti-tumour immunotherapy, which has 
already been used in animal models of cancer with 
promising results. In addition, high levels of STEAP 
mRNA have been detected in the circulation of cancer 
patients increasing the potential of STEAP as a 
diagnosing marker for human cancer. 
Homology 
Highest levels of homology with the other members of 











Prostate cancer, breast cancer, bladder cancer, lung 
cancer. STEAP1 is overexpressed in all these types of 
tumours compared to normal tissue. 
References 
Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell 
SC, Madraswala R, Zhou Y, Kuo J, Raitano AB, Jakobovits A, 
Saffran DC, Afar DE. STEAP: a prostate-specific cell-surface 
antigen highly expressed in human prostate tumors. Proc Natl 
Acad Sci U S A. 1999 Dec 7;96(25):14523-8 
Yang D, Holt GE, Velders MP, Kwon ED, Kast WM. Murine six-
transmembrane epithelial antigen of the prostate, prostate 
stem cell antigen, and prostate-specific membrane antigen: 
prostate-specific cell-surface antigens highly expressed in 
prostate cancer of transgenic adenocarcinoma mouse prostate 










Atlas Genet Cytogenet Oncol Haematol. 2010; 14(5)  484 
Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, 
Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier 
F, Tzehoval E, Eisenbach L. Human CTL epitopes prostatic 
acid phosphatase-3 and six-transmembrane epithelial antigen 
of prostate-3 as candidates for prostate cancer 
immunotherapy. Cancer Res. 2005 Jul 15;65(14):6435-42 
Rodeberg DA, Nuss RA, Elsawa SF, Celis E. Recognition of 
six-transmembrane epithelial antigen of the prostate-
expressing tumor cells by peptide antigen-induced cytotoxic T 
lymphocytes. Clin Cancer Res. 2005 Jun 15;11(12):4545-52 
Alves PM, Faure O, Graff-Dubois S, Cornet S, Bolonakis I, 
Gross DA, Miconnet I, Chouaib S, Fizazi K, Soria JC, 
Lemonnier FA, Kosmatopoulos K. STEAP, a prostate tumor 
antigen, is a target of human CD8+ T cells. Cancer Immunol 
Immunother. 2006 Dec;55(12):1515-23 
Challita-Eid PM, Morrison K, Etessami S, An Z, Morrison KJ, 
Perez-Villar JJ, Raitano AB, Jia XC, Gudas JM, Kanner SB, 
Jakobovits A. Monoclonal antibodies to six-transmembrane 
epithelial antigen of the prostate-1 inhibit intercellular 
communication in vitro and growth of human tumor xenografts 
in vivo. Cancer Res. 2007 Jun 15;67(12):5798-805 
Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM. In vivo 
effects of vaccination with six-transmembrane epithelial 
antigen of the prostate: a candidate antigen for treating 
prostate cancer. Cancer Res. 2007 Feb 1;67(3):1344-51 
Kobayashi H, Nagato T, Sato K, Aoki N, Kimura S, Murakami 
M, Iizuka H, Azumi M, Kakizaki H, Tateno M, Celis E. 
Recognition of prostate and melanoma tumor cells by six-
transmembrane epithelial antigen of prostate- 
specific helper T lymphocytes in a human leukocyte antigen 
class II-restricted manner. Cancer Res. 2007 Jun 
1;67(11):5498-504 
Maia CJ, Socorro S, Schmitt F, Santos CR. STEAP1 is over-
expressed in breast cancer and down-regulated by 17beta-
estradiol in MCF-7 cells and in the rat mammary gland. 
Endocrine. 2008 Aug-Dec;34(1-3):108-16 
This article should be referenced as such: 
Santos C, Socorro S, Maia C. STEAP1 (Six Transmembrane 
Epithelial Antigene of the Prostate 1). Atlas Genet Cytogenet 
Oncol Haematol. 2010; 14(5):482-484. 
